Study to compare the effects of AZD9496 vs Fulvestrant in breast cancer.

Trial Identifier: D6090C00002
Sponsor: AstraZeneca
NCTID:: NCT03236974
Start Date: October 2017
Primary Completion Date: February 2019

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 10117
Germany Erlangen, Germany, 91054
Germany Kiel, Germany, 24105
Germany Köln, Germany, 50935
Germany Minden, Germany, 32429
Germany Mönchengladbach, Germany, 41061
Germany München, Germany, 81377
Germany Schwerin, Germany, 19049
United Kingdom Birmingham, United Kingdom, B15 2TG
United Kingdom Bournemouth, United Kingdom, BH7 7DW
United Kingdom Derby, United Kingdom, DE22 3DT
United Kingdom Edinburgh, United Kingdom, EH4 2XU
United Kingdom London, United Kingdom, W12 0NN
United Kingdom London, United Kingdom, EC1M 6BQ
United Kingdom London, United Kingdom, SE1 9RT
United Kingdom Manchester, United Kingdom, M23 9LT
United Kingdom Poole, United Kingdom, BH15 2JB
United Kingdom Sutton In Ashfield, United Kingdom, NG17 4JL